Elliott Levy

Insider Reports History

Entity
Individual
Location
C/O Omega Therapeutics, Inc., 20 Acorn Park D, Cambridge, MA
Signature
/s/ Barbara Chan as Attorney-in-Fact for Elliott Levy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elliott Levy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. Director Stock Option (right to buy) 25K May 30, 2024 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 20, 2024 Direct

Insider Reports Filed by Elliott Levy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMGA Omega Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
EDIT Editas Medicine, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
OMGA Omega Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
EDIT Editas Medicine, Inc. Apr 11, 2023 1 $0 4 Apr 13, 2023 Director
EDIT Editas Medicine, Inc. Apr 11, 2023 0 $0 3 Apr 13, 2023 Director
OMGA Omega Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director